DETERMINING THE VALUE OF OCREVUS (R) (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

dc.contributor.authorAlerany, C.
dc.contributor.authorFernandez, R.
dc.contributor.authorLandete, L.
dc.contributor.authorRodriguez, A.
dc.contributor.authorSandoval, S.
dc.contributor.authorValdivia, M.
dc.contributor.authorGil, A.
dc.contributor.authoraffiliation[Alerany, C.] Hosp Univ Vall dHebron, Barcelona, Spain
dc.contributor.authoraffiliation[Fernandez, R.] Roche Farma SA, Madrid, Spain
dc.contributor.authoraffiliation[Landete, L.] Hosp Univ Dr Peset, Valencia, Spain
dc.contributor.authoraffiliation[Rodriguez, A.] Cruces Univ Hosp, Baracaldo, Spain
dc.contributor.authoraffiliation[Sandoval, S.] Hosp Univ Virgen Macarena, Seville, Spain
dc.contributor.authoraffiliation[Valdivia, M.] FEMM, Madrid, Spain
dc.contributor.authoraffiliation[Gil, A.] Omakase Consulting, Barcelona, Spain
dc.date.accessioned2025-01-07T16:01:27Z
dc.date.available2025-01-07T16:01:27Z
dc.date.issued2018-10-01
dc.identifier.doi10.1016/j.jval.2018.09.2064
dc.identifier.essn1524-4733
dc.identifier.issn1098-3015
dc.identifier.unpaywallURLhttp://www.valueinhealthjournal.com/article/S109830151835366X/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27568
dc.identifier.wosID459985603280
dc.issue.number3
dc.journal.titleValue in health
dc.journal.titleabbreviationValue health
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS345-S345
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.titleDETERMINING THE VALUE OF OCREVUS (R) (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number21
dc.wostypeMeeting Abstract

Files